Abstract

BackgroundPrevious cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent. We performed a meta-analysis to determine if SO is a predictor of all-cause mortality.MethodsProspective cohort studies that evaluated the association between SO and mortality in older people were identified via a systematic search of three electronic databases (PubMed, EMBASE, and the Cochrane Library). A random-effects model was applied to combine the results. We considered the methods recommeded by consensuses (dual X-ray absorptiometry,bio-impedancemetry, anthropometric measures or CT scan) to assess sarcopenic obesity.ResultsOf the 603 studies identified through the systematic review, 23 (Participants: 50866) were included in the meta-analysis. The mean age ranged from 50 to 82.5 years.SO was significantly associated with a higher risk of all-cause mortality among adult people (pooled HR = 1.21, 95% confidence interval [95% CI] = 1.10–1.32, p < 0.001, I2 = 64.3%). Furthermore, the subgroup analysis of participants showed that SO was associated with all-cause mortality (pooled HR = 1.14, 95% CI: 1.06–1.23) among community-dwelling adult people; similarly, this association was found in hospitalized patients (pooled HR = 1.65, 95% CI: 1.17–2.33). Moreover, the subgroup analysis demonstrated that SO was associated with all-cause mortality when using skeletal muscle mass (SMM) criteria, muscle strength criteria, and skeletal muscle index (SMI) criteria (HR = 1.12, 95% CI: 1.01–1.23; HR = 1.18, 95% CI: 1.05–1.33; and HR = 1.53, 95% CI: 1.13–2.07, respectively). In addition, we analyzed SO on the basis of obesity definition and demonstrated that participants with a SO diagnosis based on waist circumference (WC) (HR = 1.24, 95% CI: 1.09–1.40), body mass index (BMI) (HR = 1.29, 95% CI: 1.04–1.59), or visceral fat area (HR = 2.54, 95% CI: 1.83–3.53) have a significantly increase mortality risk compared with those without SO.ConclusionBased on our update of existing scientific researches, SO is a significant predictor of all-cause mortality among older people, particularly hospitalized patients. Therefore, it is important to diagnose SO and to treat the condition to reduce mortality rates among older people.

Highlights

  • Previous cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent

  • We found the sensitivity analysis of age group showed that Participants age 50–70 years with SO was associated with all-cause mortality; participants with SO aged 70 years and older did have a marginally association (Additional file 5: Figure S4)

  • Our study found that people with SO significantly increase the risk of mortality with a 1.21-fold risk comparing to non-sarcopenic non-obese

Read more

Summary

Introduction

Previous cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent. Sarcopenia is defined as a condition of age-related loss of muscle mass and muscle strength with functional impairment in terms of physical performance, and it has been associated with a series of adverse health consequences among older adults [1], including falls [1] and fractures [2], decreased mobility [3], depression [4], poor quality of life [5], hospitalization [6], and mortality [7]. The prevalence of obesity in the adult people of the world is rising alarmingly [8], potentially augmenting supplemental conditions and increasing the risk of adverse health outcomes. Given the fact that both sarcopenia and obesity would increase the risk of all-cause mortality [13, 14], it is hypothesized that the coexistence of sarcopenia and obesity may synergistically aggravate the risk of mortality

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call